Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-05-27
1998-10-06
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514171, 514180, 514863, A61K 3147
Patent
active
058176756
ABSTRACT:
8-Hydroxyquinoline is useful in the topical treatment of inflammatory proliferative skin diseases, especially psoriasis. It should be applied from an essentially anhydrous vehicle.
REFERENCES:
patent: 3944668 (1976-03-01), Cleaver
patent: 4038388 (1977-07-01), Cleaver
Nordenberg et al, Eur.J. Cancer, vol. 26, No. 8, pp. 905-907 (1990).
Minnich et al, Dermatology Nursing, vol. 3, No. 1, pp. 25-28 (1991).
Gupta, J. Pharmi. Sci., 71(5):585-7 (1982).
Chemical Abstracts, 97/133427 (1982); 88:55014 (1977); 84:169598 (1976).
"The Merck Manual" (11th Edition) Lyght et al., Merck, Sharp & Dohme Research Laboratories (1966) pp. 1431-1433.
"The Merck Index" (11th Ed.), Budavari et al. Merck and Co., Inc., Rahway, N.J., 1989, pp. 184,769,770, and 1153.
WPIDS Abstract, AN 81-89674d, 1981, B.W. Fisher et al.
WIPDS Abstract, AN 81-89673d, 1981, B.W. Fisher.
Diomed Developments Limited
Moezie M.
Weddington Kevin E.
LandOfFree
Compositions for the treatment of psoriasis and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for the treatment of psoriasis and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for the treatment of psoriasis and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-77519